"Joshua Kiernan is well known for advising Israeli clients on a range of ECM matters including IPOs and secondary capital raises. His clients include both issuers and underwriters." Chambers UK 2018

Joshua Kiernan is the only lawyer ranked as a “Star Individual” for Corporate/M&A in Israel by Chambers Global 2015, described as “supreme for Israeli ECM" and does a "phenomenal job."

Sources state: “He is acclaimed for his focus on Israel, and highlighted for his extensive experience of high-end IPOs.” Chambers Global 2015

Joshua G. Kiernan

London
  • 99 Bishopsgate
  • London EC2M 3XF
  • United Kingdom
 
 

Joshua Kiernan has extensive experience advising Israeli companies on Securities and Exchange Commission (SEC)-registered IPOs, follow-on and secondary offerings, block trades, private placements and Rule 144A offerings. In addition, his practice includes advising on a variety of debt offerings (including high yield and sovereign bonds) and cross-border M&A, joint ventures, and leveraged buyouts.

Mr. Kiernan assists clients with SEC-compliance and corporate governance matters, as well as Financial Industry Regulatory Authority (FINRA) issues.

 

Mr. Kiernan’s representative transactions include advising:

  • Israel Chemicals Ltd., a leading global specialty minerals and specialty chemicals company, on the US$1 billion sale of its fire safety and oil additives businesses to SK Capital Partners
  • Cnova N.V. and its parent company Groupe Casino on its reorganization and spin-off of Groupe Casino's eCommerce businesses, by way of an US$188 million IPO on NASDAQ*
  • The underwriters on the £405 million IPO of cyber security company Sophos PLC on the London Stock Exchange*
  • The underwriters on the US$1.6 billion IPO and privatisation of Oil Refineries Ltd. on the Tel Aviv Stock Exchange pursuant to Rule 144A – the largest-ever IPO in Israel*    
  • Numerous Israeli and European technology and life sciences companies on SEC-registered IPOs on NASDAQ and the NYSE, including: Mediwound; Luxoft; Allot Communications; Evogene; Saifun; and Voltaire*    
  • The underwriters on numerous IPOs and secondary and follow-on offerings on NASDAQ and the NYSE by technology and life sciences companies, including: SodaStream; Magic Software; Sapiens; Lumenis; QIWI; Mellanox; MediaMind; Foamix; PowerDsine and Aladdin*
  • B Communications on its US$800 million high yield bond offering - the first-ever international bond offering listed on the Tel Aviv Stock Exchange*
  • The underwriters on the convertible bond offering by Audiocodes*
  • Antargaz on its Rule 144A high yield bond offering*
  • Viber Media on its US$900 million all-cash sale to Rakuten Inc.*
  • Provigent on its US$350 million sale to Broadcom*

*matter handled prior to joining the firm

 

 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.